Danaher Co. (NYSE:DHR) Stake Cut by Empirical Financial Services LLC d.b.a. Empirical Wealth Management

Empirical Financial Services LLC d.b.a. Empirical Wealth Management decreased its holdings in shares of Danaher Co. (NYSE:DHR) by 17.3% in the 4th quarter, Holdings Channel reports. The firm owned 21,030 shares of the conglomerate’s stock after selling 4,396 shares during the quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management’s holdings in Danaher were worth $4,828,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Jamison Private Wealth Management Inc. raised its stake in Danaher by 1.7% during the fourth quarter. Jamison Private Wealth Management Inc. now owns 9,756 shares of the conglomerate’s stock worth $2,239,000 after acquiring an additional 159 shares during the period. First Citizens Bank & Trust Co. raised its position in shares of Danaher by 1.4% during the 4th quarter. First Citizens Bank & Trust Co. now owns 40,422 shares of the conglomerate’s stock worth $9,279,000 after purchasing an additional 561 shares during the period. Investment Research & Advisory Group Inc. lifted its holdings in shares of Danaher by 3.4% in the 4th quarter. Investment Research & Advisory Group Inc. now owns 5,338 shares of the conglomerate’s stock worth $1,225,000 after purchasing an additional 177 shares during the last quarter. Duncan Williams Asset Management LLC boosted its position in Danaher by 7.2% during the 4th quarter. Duncan Williams Asset Management LLC now owns 4,477 shares of the conglomerate’s stock valued at $1,028,000 after purchasing an additional 301 shares during the period. Finally, Affiance Financial LLC grew its stake in Danaher by 54.4% during the 4th quarter. Affiance Financial LLC now owns 1,135 shares of the conglomerate’s stock worth $169,000 after buying an additional 400 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have recently issued reports on DHR shares. Stephens reissued an “overweight” rating and set a $315.00 price target on shares of Danaher in a report on Wednesday, October 23rd. Evercore ISI boosted their target price on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. TD Cowen raised their price target on shares of Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a research report on Thursday, October 31st. Finally, Barclays lowered their target price on Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $285.55.

Danaher Stock Up 0.1 %

DHR stock opened at $245.95 on Monday. The firm has a market cap of $177.65 billion, a PE ratio of 46.94, a P/E/G ratio of 4.43 and a beta of 0.83. Danaher Co. has a 12 month low of $225.42 and a 12 month high of $281.70. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The firm has a 50 day simple moving average of $235.33 and a 200 day simple moving average of $253.54.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s dividend payout ratio is presently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.